Slime-producing properties of coagulase-negative staphylococci isolated from blood cultures  by Mulder, J.G. & Degener, J.E.
ORIGINAL ARTICLE 
Slime-producing properties of coagulase-negative 
staphylococci isolated from blood cultures 
Clin Microbiol Infect 1998; 4: 689-694 
J G. Muldevl andJ E. Degener2 
'Department of Bacteriology, Regional Public Health Laboratory, and 2Department of Medical 
Microbiology, University Hospital, Groningen, The Netherlands 
Objective: To evaluate five methods for the determination of slime-producing properties in  coagulase-negative 
staphylococci (CNS). 
Methods: One hundred and sixty-two strains of CNS considered as 'contaminants' and 162 strains associated with 
'bacteremia' were tested with the tube test with tryptic soy broth, the tube test with brain-heart infusion broth 
supplemented with 5% sucrose, the Congo red agar method, and the microtiter-plate test with trypan blue and crystal 
violet, both with tryptic soy broth. 
Results: Of the 324 strains tested, 188 were negative and 58 were positive with all methods. The remaining 78 strains 
were positive with one or more methods. 
Conclusions: There was a significant difference (p<O.OOI) in  slime production between 162 strains of CNS pertaining 
to  'bacteremia' and 162 strains considered as 'contaminants', with 84 (51.8%) and 52 (32.8%) positive, respectively. The 
slime-producing strains were significantly more resistant (p<O.OOI) to cloxacillin, tobramycin, gentamicin, trimethoprim, 
erythromycin and ciprofloxacin. 
Key words: Coagulase-negative staphylococci, slime production, bacteremia 
I NTROD UCTl ON 
Coagulase-negative staphylococci (CNS) are in- 
creasingly important as nosocomial pathogens, mainly 
because of the use of intravascular catheters and 
prosthetic devices in seriously ill immunocompromised 
patients. Staphylococci are the microorganisms most 
frequently isolated &om blood in episodes of bacteremia 
in these patients [l]. Some strains of CNS can be 
characterized by their ability to produce extracellular 
slime. Bayston and Penny [2] have reported the 
significance of a mucoid substance for the colonization 
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of Holter shunts. Together with other elemental 
substances [3-51 and bacteria, this substance can form 
a biofilm on prosthetic devices in which the bacteria 
may be protected from immunologic host defence 
mechanisms and antimicrobial agents [6-91. Some 
investigators have indicated a significant difference in 
slime-producing properties between clinically relevant 
strains and contaminants of CNS [lo-151. In other 
studies, however, this could not be confirmed [16-181. 
These conflicting results may be due in part to 
differences in the test performed and the composition 
of the strain collection [19-251. 
The aim of this study was to compare five different 
methods of determining slime production: the tube test 
with tryptic soy broth (TSB) [12], the tube test with 
brain-heart infusion (BHI) broth supplemented with 
5% sucrose [26], the Congo red agar method [26], and 
the microtiter-plate test with trypan blue or crystal 
violet, both with TSB [27]. Furthermore, we compared 
strains of CNS considered to be associated with 
bacteremia and strains considered to be contaminants 
for a difference in slime production, and we searched 
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for a difference in susceptibility patterns between slime- 
and non-slime-producing strains. 
MATERIALS AND METHODS 
Bacterial strains 
The strains of CNS, stored at -70°C in skimmed milk, 
were isolated from blood cultures submitted to our 
laboratory by the University Hospital, Groningen, in a 
3-year period (1 990-92). The University Hospital had 
1084 beds and 26 000 adniissions per year. 
Blood cultures 
One blood culture set consisted of two bottles-an 
‘aerobic’ qaponin broth bottle, and an ‘anaerobic’ 
Schaedler broth bottle (Oxoid, Basingstoke, UK)- 
which were incubated for 6 days at 35OC. Strains of 
CNS isolated from these blood cultures were con- 
sidered to be causing ‘bacteremia’ if at  least two 
consecutive blood cultures collected within a period of 
6 days were positive with a strain of CNS with the same 
susceptibility pattern for 12 antimicrobial agents (see 
later) and the same species identification. Strains of 
CNS from positive blood cultures that did not meet 
these criteria were considered to be ‘contaminants’ 
[17,28,29]. 
In the period 1990-92, the total number of blood 
cultures submitted to our laboratory was 18 920. Of  
these blood cultures, 1949 (10.3%) were positive. When 
each patient was counted only once, 1213 (6.4%) were 
recorded as positive aiid CNS were isolated in 893 of 
these; 162 were considered to represent ‘bacteremia’. 
Of  the remaining 730 blood cultures, which were 
considered to be ‘contaminated’, 501 had just one 
bottle positive with CNS. From these 501 strains of 
CNS, 162 strains were randomly chosen to form a 
collection of ‘contaminants’. 
identification of strains 
Strains were identified by colony morphology, Gram 
stain, catalase reaction [17,30,3 11, resistance to bacitracin 
(TaxoA bacitracin disk 0.04 U; BBL, Cockeysville, 
MI], USA) [32], coagulase reactions (slide and tube, 
bactocoagulase EDTA; Difco, Detroit, MD, USA), 
DNase test on IlNase agar (Oxoid, UK) [17,30,31], 
and the API Staph system (bioMkrieux, Marcy I’Etoile, 
France). 
Susceptibility tests 
The testing of susceptibility to penicillin, gentaniicin, 
tobramycin, trimethoprini, tetracycline, erythroniycin, 
ciprofloxacin and vancomycin was performed with a 
standardized agar dilution method [33] .  The agar used 
was Diagnostic Sensitivity Test agar with 5% hemolysed 
horse blood (Oxoid). The breakpoints were in accord- 
ance with the NCCLS standards [34]. 
The susceptibility to oxacillin was tested as described 
by Mulder [35] with a 5 p g  oxacillin disk (Oxoid), 
Mueller-Hinton agar with 2% NaCl and 24 h of 
incubation at 35OC. The susceptibilities of the strains to 
rifampicin (30 pg), teicoplanin (60 pg) and fusidic acid 
(400 pg) were tested with the use of neosensitabs 
(Rosco Diagnostica, Taastrup, Denmark). These tests 
were performed on Isosensitest agar (Oxoid) following 
the criteria of the ICS 1361. The corresponding break- 
points are shown in Table 4. Stuplzylococcur epidermidis 
ATCC 12228 was used as a control strain. 
Qualitative tube test for slime production 
The qualitative assessment of slime production was 
carried out as described by Christensen et a1 [12]. Glass 
tubes with 2 mL TSB containing 0.25% glucose 
(Oxoid), 2 mL TSB without glucose (Difco) or 2 m L  
BHI broth (Brocacef, Maarssen, The Netherlands) 
supplemented with 5% sucrose (Brocacef) were 
inoculated with a single colony of a pure culture of a 
strain of CNS and incubated for 24 h at  35°C. The 
content was then decanted and 2 inL of a 0.4% solution 
of trypan blue (Sigma Chemical Co., St Louis, 
Missouri, USA) was added. The tube was rotated 
gently to reveal any staining of adherent material on the 
inner surface. The tube was placed upside down to 
drain. The test was considered positive when there was 
an adherent layer of stained material on the inner 
surface of the tube. The presence of stained material a t  
the liquid-air interface was not considered to be 
indicative of slime production. ATCC 35982, a non- 
slime producer (tube test -). ATCC 35983, a moderate 
slime producer (tube test +), and ATCC 35984, a 
strong slime producer (tube test ++) served as controls 
1121. 
Quantitative microtiter-plate test for slime production 
This method has been previously described by 
Christensen et al [26]. Four wells of a sterile 96-well 
inicrotiter plate (INC Biomedicals BV. Zoetermeer, 
The Netherlands) were filled with a 0.2-mL aliquot of 
TSB diluted 1: 100 overnight and containing 0.25% 
glucose (Oxoid). The plates were prepared in duplicate. 
The strains ATCC 35982, a non-slime producer, 
ATCC 35983, a moderate slime producer, ATCC 
35984, a strong slime producer 1131, and broth without 
a bacterial strain served as controls. The plates were 
covered and incubated for 24 h at 35°C. One of the 
two plates was emptied and the adherent organisnis 
were colored with trypan blue solution as described for 
the qualitative tube test. From the second plate the 
contents of each well were gently aspirated, and the 
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wells were washed four times with 0.2 mL phosphate- 
buffered saline (pH 7.2). The adherent organisms were 
fixed with Bouin fixative [24] and stained with crystal 
violet. Excess stain was gently rinsed offwith tap water. 
After the plates were dried, the optical density of 
stained adherent films was measured with an MC 340 
Titertek Multiscan (ICN Biomedicals) with a wave- 
length of 620 nm. The optical density for each strain 
was assessed in quadruplicate and the values were 
averaged. The cut-off optical density for the microtiter- 
plate test was the mean optical density +3 SD of the 
slime-negative ATCC 35982 strain (Table 1). 
Congo red agar method 
This test was performed as described by Freeman et a1 
[27]. The medium was composed of BHI broth 
(Oxoid) 37 g/L, sucrose (Brocasef) 50 g/L, agar no. 1 
(Oxoid) 10 g/L and Congo red (Sigma Chemical Co., 
St Louis, Missouri, USA) 0.8 g/L. A concentrated 
solution of Congo red was added after separate 
autoclaving (121°C for 15 min), when the agar with 
the other constituents had cooled down to 55°C. The 
plates were inoculated with one colony of a pure 
culture, incubated at 31OC and read after 24 and 48 h. 
A positive result was indicated by black colonies with a 
dry crystalline consistency after 24 h (++) or 48 h (+) 
of incubation. ATCC 35982, a non-slime-producing 
strain (-), ATCC 35983, a moderate slime producing 
strain (++), and ATCC 35984, a strong slime- 
producing strain (++), served as controls. 
Statistical methods 
Statistical differences in species distribution between 
‘contaminants’ and strains pertaining to ‘bacteremia’ 
were calculated with the chi-square test; statistical 
differences in slime production and sensitivity were 
calculated with the chi-square test with Yates’ cor- 
rection. 
Table 1 shows the intertest variability of the five 
methods to determine slime production in CNS of the 
ATCC 35982, 35983, 35984 strains and the broth 
control. For the cut-off OD, the mean OD + 3 SD of 
the slime-negative ATCC 35982 strain was used, being 
0.13 and 0.09 for trypan blue and crystal violet, 
respectively. 
Table 2 shows the results of the five tests for the 
determination of slime production in CNS: the tube 
test with TSB, the tube test with BHI broth, the Congo 
red agar method (CR), and the microtiter-plate test 
with trypan blue (T) and crystal violet (C). The tube 
test and microtiter-plate test with TSB without sugar 
did not yield any positive result. O f  the 324 strains 
tested, 188 were negative and 58 were positive with all 
methods. The remaining 78 strains were positive with 
one or more methods. The numbers with discordant 
negative results were, respectively, 29, 47, 55, 71 and 
43 with TSB, BHI broth, CR, T and C. Of  the 29 
strains negative with TSB, one was positive with BHI 
Table 1 The intertest variability of five methods for the determination of slime production in coagulase-negative 
staphylococci (n=9) 
Tube test + TSB Tube test BHI Congo red agar Trypan blue Crystal violet 
Strain - + ++ - - ++ - + ++ Mean2 SD Mean ? SD 
Broth only 9 - - 9 - - 9 - - 0.06?0.02 0.0520.01 
ATCC 35982 9 - - 9 - - 9 - - 0.0720.02 0.0620.01 
ATCC 35983 9 3 6 - 9 0.102 0.05 0.11 k0.06 
ATCC 35984 - - 9 4 4 1 - - 9 0.54k0.18 1 ,002 0.12 
TSB, tryptic soy broth; BHI, brain-heart infusion broth. 
- - - - 
Table 2 Comparison between five different methods for the determination of slime production in coagulase-negative 
staphylococci (M =324) 
Microtiter-plate test 
Tube test BHI Congo red agar Trypan blue Crystal violet 
+ + - - Tube test TSB - + ++ - + ++ 
++ 85 4 37 44 25 4 56 29 56 20 65 
+ 22 15 7 - 11 - 11 20 2 11 11 
- 217 216 - 1 207 - 10 210 7 200 17 
TSB, tryptic soy broth; BHI, brain-heart infusion broth. 
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Table 3 Species distribution and slime production of coagulase-negative staphylococci recovered from blood cultures 
Contaminants Bacterenlla 
Slime SllIllC 
SQeclCS I1 'XI positive' % 11 96 poqitive" 94 
S. epidermidis 115 71.0h 45 27.8 137 84.6h 83 51.2 
s .  IlaPmolytrclu I t  6.8 11 8.6 - ~ 
S .  iiurtieri 7 4.3 3 1.8 1 I .9 1 0.6 
S. /ioriiitiis 9 5.6 2 1.2 3 2.5 ~ 
s. ciipirrs 6 3.7 1 0.6 1 0.6 
~ - - S. Iirydirnetisi, 1 11.6 
S. cc/i[e[fcri 4 2 i 1 0.6 ~ 
s. sylosrrs I 1.2 
~ 
7 ~ ~ - 
No identification 8 4.9 1 0.6 1 0.6 
Total 162 1no.o 52 32.0' 162 100.0 81 51.8' 
"Positive in one or more of the five tests. 
"Significant difference in species distribution, p=0.002 (chi-square test) 
'Significant difference in slime production, p<0.001 (chi-square test with Yates' correction). 
Table 4 Comparison of susceptibility between slime- 
negative and slime-positive strains of coagulase-negative 
staphylococci 
Slime Slime 
Antim~robial MIC negative positive 
agent < (mg/L) ri=188 ("A) n=136 (%) pi 
l'emcilhn 
Closacillin 
Tobi-amycin 
Gcntniiucin 
Trmicthoprnn 
Tetr'icychne 
Er\throiiiycin 
Ciprofloxmii 
Teicoplaniii 
Rifnmpicin 
Fusidic acid 
v m i  onlycln 
25 (17) 
71 (78) 
97 (51) 
112 (59) 
114 (61) 
117 (73) 
1 I6 (62) 
188 ( lol l )  
188 (100) 
I 0 0  (85) 
185 (99) 
187 ('19) 
7 (5) 
26 (t9) 
211 (15) 
31 (23) 
28 (21) 
87 (64) 
51 (37) 
136 (100) 
136 (100) 
136 (100) 
76 (36) 
129 (95) 
"p,  xatimcal differenre between dime-negative and dime-positive 
stram, chi-quare tett with Y.ito' correction. 
broth (++) and CR (++) (S. horninic), one was positive 
with C R  (++) and C (S. epidermidis), eight were 
positive with C R  (++) done (S. epidermidix, n=6; S. 
horiririis, t t = l ;  S. irurneri, n=l ) ,  four were positive with 
T and C (S. epidevmidis, u = I ;  S. waraeri, n = l ;  S. cupitis, 
n = l ;  and one strain without identification), three were 
positive with T alone (S. epidermidis, n=2; S. cupitis, 
n = l ) ,  and 12 were positive with C alone (S. epidermidis, 
f i = l l ;  S. imrnevi, r ~ = l ) .  
Between the two groups of strains, 'contaminants' 
(t1=162) and strains representing 'bacteremia' (n=162),  
there was a significant difference in species distribution 
(p=0.002) and number of slime-producing strains 
(y<O.OOI) (Table 3). The slime-producing strains were 
significantly (p<O.OOl) more resistant to cloxacillin, 
tobramycin, genzaniicin, trimethoprim, erythroniycin 
and ciprofloxacin. There was no significant difference 
for penicillin and tetracycline. All strains were susceptible 
to vancomycin and teicoplanin (Table 4). 
DISCUSSION 
The inucoid substance produced by some strains of 
CNS, previously described by Bayston and Penny [2], 
consists of glycoprotein and polysaccharide [27,37]. 
The chemical constitution of thic extracellular slime 
depends on the composition of the medium and the 
culture conditions [19,24,37]. Together with elemental 
substances and bacteria L3-51, this slimy substance can 
form a biofilin on glass and plastic surfaces, the degree 
of adherence of which depends on the structure of the 
underlying material. Little is currently known about a 
genetic base for biofilni formation. Muller et al [38] 
and Heilinann et nl [39] found transposon mutants 
of S. rpidevriiidis with deficient elaboration of slime. 
Mempel et a1 [40] mentioned auxiliary genes of 
inethicillin resistance regulation and their possible 
influence on virulence factors in CNS. Ziebuhr et a1 
[41] described an intercellular adhesion gene cluster. 
In our investigation, TSB without glucose did not 
yield any positive result in the tube test, or in the 
microtiter-plate test. We therefore concluded that a 
sugar coniponent is a necessary ingredient for satis- 
factory results in any test, a conclusion that contradicts 
the results of Christensen et a1 [20]. In the tube test, 
TSB always resulted in more stained material on the 
inner surface of the tube than BHI broth, so a protein 
component obviously enhanced the test results. The 
microtiter-plate test was time-consuming and the 
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adherent layer was easily disrupted by washing. The 
advantage of objective measurement did not counter- 
balance the drawbacks of the test. AU the tests gave a 
considerable number of negative results in cases in 
which one or more of the other tests were positive. 
Because no test exists to determine true positivity, the 
sensitivity and specificity could not be calculated [42]. 
Therefore, only the numbers of discordant results are 
given. 
Sometimes it is important, for deciding on the 
course of medical action, to know if there is biofilm 
formation, e.g. in cases of endocarditis and infections 
in chronic ambulatory peritoneal dialysis patients. In 
such cases our conclusion would be that the tube test 
with TSB and trypan blue is the most feasible method. 
The use of slime production as a pathogenic 
property of CNS strains has led to conflicting results in 
different investigations. Some confirm the production 
of slime as a pathogenic feature [IO-151, while others 
contradict this [ 16-1 81. These divergent results may be 
due to the test used as well as to the composition of the 
investigated collection of strains. We found a significant 
difference in slime production (p=0.004) between the 
strains (n=162) associated with ‘bacterernia’ and the 
strains (nzl62) considered as ‘contaminants’ (Table 3). 
However, the considerable number of strains positive 
in the ‘contaminants’ group (52) makes the test 
unsuitable for discrimination between ‘contaminant’ 
and ‘bacteremia’ strains in clinical diagnosis. In addition, 
we cannot rule out the possibility that some of the 
strains designated as ‘contaminants’ were, in fact, 
associated with bacteremia, because our criteria were 
not based on clinical symptoms. 
There was a difference in susceptibility to anti- 
biotics between slime producers and non-slime pro- 
ducers (Table 4), which confirms the results of some 
investigators [1,13,16], though not those of others 
115,431. 
More research has to be done, with the aid of 
modern techniques and in clinical trials, to investigate 
the pathogenesis of slime production. 
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